This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. (MRNA) rose 1.38% to $137.74 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.90% to 11,448.40 and Dow Jones Industrial Average falling 0.45% to 30,822.42. Moderna Inc. closed $320.76 below its 52-week high ($458.50), which the company achieved on September 23rd.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as AbbVie Inc. (ABBV) rose 1.09% to $144.06, Amgen Inc. (AMGN) rose 1.53% to $231.14, and AstraZeneca PLC ADR (AZN.LN) fell 0.15% to $58.05. Trading volume (7.5 M) eclipsed its 50-day average volume of 4.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 16, 2022.
(END) Dow Jones Newswires
September 16, 2022 16:32 ET (20:32 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.